Misplaced Pages

Ovaprene

Article snapshot taken from Wikipedia with creative commons attribution-sharealike license. Give it a read and then ask your questions in the chat. We can research this topic together.
This article is an orphan, as no other articles link to it. Please introduce links to this page from related articles; try the Find link tool for suggestions. (December 2023)

Ovaprene is an experimental non-hormonal contraception developed by Daré Bioscience that is composed of an intervaginal device that releases ferrous gluconate, ascorbic acid, and glycine.

References

  1. Svoboda, Elizabeth (16 December 2020). "Better birth control". Nature. 588 (7838): S166 – S167. Bibcode:2020Natur.588S.166S. doi:10.1038/d41586-020-03532-6. PMID 33328681. S2CID 229302708.
  2. Silverwood, Joshua (4 December 2023). "Daré Bioscience launches Phase III hormone-free contraceptive trial". Clinical Trials Arena. Retrieved 5 December 2023.
  3. Researchers Investigate Contraceptive Vaginal Ring. Source: Contraceptive Technology Update . Jul2019, Vol. 40 Issue 7, p0-0. 1p. Author(s): AHC MEDIA
  4. Mauck, Christine K; Vincent, Kathleen L (4 August 2020). "The postcoital test in the development of new vaginal contraceptives†". Biology of Reproduction. 103 (2): 437–444. doi:10.1093/biolre/ioaa099. PMC 7401356. PMID 32657328.
Category: